Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 14, 2014; 20(42): 15820-15829
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15820
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15820
Table 2 Multivariate analysis of disease-free survival
Variable | Main cohort | External reference cohort | ||
HR (95%CI) | P value | HR (95%CI) | P value | |
Type of response after CRT | ||||
ypT0N0 | 0.07 (0.01-0.54) | 0.0100 | 0.51 (0.15-1.7) | 0.2700 |
ypT1-2N0 | 0.16 (0.06-0.46) | 0.0007 | 0.41 (0.18-0.94) | 0.0360 |
ypT3-4/N1-2 | Reference | Reference | ||
CEA | 1.02 (1.01-1.03) | 0.0010 | 1.02 (1.01-1.03) | 0.0072 |
Pre-surgery clinical stage | ||||
T2-3N0 | Reference | Reference | ||
T4 and/or N1 | 1.19 (0.82-1.73) | 0.3500 | 1.66 (0.85-3.26) | 0.1400 |
Admission stay after surgery1, d | 1.02 (1.01-1.02) | 0.0020 |
- Citation: García-Albéniz X, Gallego R, Hofheinz RD, Fernández-Esparrach G, Ayuso-Colella JR, Bombí JA, Conill C, Cuatrecasas M, Delgado S, Ginés A, Miquel R, Pagés M, Pineda E, Pereira V, Sosa A, Reig O, Victoria I, Feliz L, María de Lacy A, Castells A, Burkholder I, Hochhaus A, Maurel J. Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation. World J Gastroenterol 2014; 20(42): 15820-15829
- URL: https://www.wjgnet.com/1007-9327/full/v20/i42/15820.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i42.15820